Supplementary figures and table from Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib Article Swipe
Judith Raimbourg
,
Marie‐Pierre Joalland
,
Mathilde Cabart
,
Ludmilla de Plater
,
Fanny Bouquet
,
Ariel Savina
,
Didier Decaudin
,
Jaafar Bennouna
,
François M. Vallette
,
Lisenn Lalier
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.22507992
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.22507992
Supplementary figures and table described in the manuscript
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1535-7163.22507992
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362612498
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362612498Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1535-7163.22507992Digital Object Identifier
- Title
-
Supplementary figures and table from Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor ErlotinibWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-03Full publication date if available
- Authors
-
Judith Raimbourg, Marie‐Pierre Joalland, Mathilde Cabart, Ludmilla de Plater, Fanny Bouquet, Ariel Savina, Didier Decaudin, Jaafar Bennouna, François M. Vallette, Lisenn LalierList of authors in order
- Landing page
-
https://doi.org/10.1158/1535-7163.22507992Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1535-7163.22507992Direct OA link when available
- Concepts
-
Erlotinib, Tyrosine-kinase inhibitor, Medicine, Tyrosine kinase, Cancer research, Sensitization, Lung cancer, Wild type, Kinase, Oncology, Internal medicine, Cancer, Chemistry, Epidermal growth factor receptor, Immunology, Receptor, Gene, Biochemistry, MutantTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362612498 |
|---|---|
| doi | https://doi.org/10.1158/1535-7163.22507992 |
| ids.doi | https://doi.org/10.1158/1535-7163.22507992 |
| ids.openalex | https://openalex.org/W4362612498 |
| fwci | |
| type | preprint |
| title | Supplementary figures and table from Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10417 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9948999881744385 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Lung Cancer Treatments and Mutations |
| topics[1].id | https://openalex.org/T11395 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9394999742507935 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | Radiopharmaceutical Chemistry and Applications |
| topics[2].id | https://openalex.org/T10755 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9211999773979187 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | HER2/EGFR in Cancer Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778087573 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9529993534088135 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q418369 |
| concepts[0].display_name | Erlotinib |
| concepts[1].id | https://openalex.org/C2778820342 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6423038244247437 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q906415 |
| concepts[1].display_name | Tyrosine-kinase inhibitor |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6016995906829834 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C42362537 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5931893587112427 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q87099740 |
| concepts[3].display_name | Tyrosine kinase |
| concepts[4].id | https://openalex.org/C502942594 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5930917263031006 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[4].display_name | Cancer research |
| concepts[5].id | https://openalex.org/C2776217527 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5319659113883972 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q944828 |
| concepts[5].display_name | Sensitization |
| concepts[6].id | https://openalex.org/C2776256026 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5227025747299194 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q47912 |
| concepts[6].display_name | Lung cancer |
| concepts[7].id | https://openalex.org/C207583985 |
| concepts[7].level | 4 |
| concepts[7].score | 0.4360957145690918 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q128723 |
| concepts[7].display_name | Wild type |
| concepts[8].id | https://openalex.org/C184235292 |
| concepts[8].level | 2 |
| concepts[8].score | 0.41847991943359375 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q421851 |
| concepts[8].display_name | Kinase |
| concepts[9].id | https://openalex.org/C143998085 |
| concepts[9].level | 1 |
| concepts[9].score | 0.38145336508750916 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[9].display_name | Oncology |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.34850436449050903 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C121608353 |
| concepts[11].level | 2 |
| concepts[11].score | 0.33575356006622314 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[11].display_name | Cancer |
| concepts[12].id | https://openalex.org/C185592680 |
| concepts[12].level | 0 |
| concepts[12].score | 0.2605605125427246 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[12].display_name | Chemistry |
| concepts[13].id | https://openalex.org/C2779438470 |
| concepts[13].level | 3 |
| concepts[13].score | 0.24828296899795532 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q424401 |
| concepts[13].display_name | Epidermal growth factor receptor |
| concepts[14].id | https://openalex.org/C203014093 |
| concepts[14].level | 1 |
| concepts[14].score | 0.14637860655784607 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[14].display_name | Immunology |
| concepts[15].id | https://openalex.org/C170493617 |
| concepts[15].level | 2 |
| concepts[15].score | 0.09630182385444641 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[15].display_name | Receptor |
| concepts[16].id | https://openalex.org/C104317684 |
| concepts[16].level | 2 |
| concepts[16].score | 0.07030779123306274 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[16].display_name | Gene |
| concepts[17].id | https://openalex.org/C55493867 |
| concepts[17].level | 1 |
| concepts[17].score | 0.05373948812484741 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[17].display_name | Biochemistry |
| concepts[18].id | https://openalex.org/C143065580 |
| concepts[18].level | 3 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q3285695 |
| concepts[18].display_name | Mutant |
| keywords[0].id | https://openalex.org/keywords/erlotinib |
| keywords[0].score | 0.9529993534088135 |
| keywords[0].display_name | Erlotinib |
| keywords[1].id | https://openalex.org/keywords/tyrosine-kinase-inhibitor |
| keywords[1].score | 0.6423038244247437 |
| keywords[1].display_name | Tyrosine-kinase inhibitor |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.6016995906829834 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/tyrosine-kinase |
| keywords[3].score | 0.5931893587112427 |
| keywords[3].display_name | Tyrosine kinase |
| keywords[4].id | https://openalex.org/keywords/cancer-research |
| keywords[4].score | 0.5930917263031006 |
| keywords[4].display_name | Cancer research |
| keywords[5].id | https://openalex.org/keywords/sensitization |
| keywords[5].score | 0.5319659113883972 |
| keywords[5].display_name | Sensitization |
| keywords[6].id | https://openalex.org/keywords/lung-cancer |
| keywords[6].score | 0.5227025747299194 |
| keywords[6].display_name | Lung cancer |
| keywords[7].id | https://openalex.org/keywords/wild-type |
| keywords[7].score | 0.4360957145690918 |
| keywords[7].display_name | Wild type |
| keywords[8].id | https://openalex.org/keywords/kinase |
| keywords[8].score | 0.41847991943359375 |
| keywords[8].display_name | Kinase |
| keywords[9].id | https://openalex.org/keywords/oncology |
| keywords[9].score | 0.38145336508750916 |
| keywords[9].display_name | Oncology |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.34850436449050903 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/cancer |
| keywords[11].score | 0.33575356006622314 |
| keywords[11].display_name | Cancer |
| keywords[12].id | https://openalex.org/keywords/chemistry |
| keywords[12].score | 0.2605605125427246 |
| keywords[12].display_name | Chemistry |
| keywords[13].id | https://openalex.org/keywords/epidermal-growth-factor-receptor |
| keywords[13].score | 0.24828296899795532 |
| keywords[13].display_name | Epidermal growth factor receptor |
| keywords[14].id | https://openalex.org/keywords/immunology |
| keywords[14].score | 0.14637860655784607 |
| keywords[14].display_name | Immunology |
| keywords[15].id | https://openalex.org/keywords/receptor |
| keywords[15].score | 0.09630182385444641 |
| keywords[15].display_name | Receptor |
| keywords[16].id | https://openalex.org/keywords/gene |
| keywords[16].score | 0.07030779123306274 |
| keywords[16].display_name | Gene |
| keywords[17].id | https://openalex.org/keywords/biochemistry |
| keywords[17].score | 0.05373948812484741 |
| keywords[17].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.1158/1535-7163.22507992 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1535-7163.22507992 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5071502431 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2950-490X |
| authorships[0].author.display_name | Judith Raimbourg |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Judith Raimbourg |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5112440490 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Marie‐Pierre Joalland |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Marie-Pierre Joalland |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5073496258 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3132-0069 |
| authorships[2].author.display_name | Mathilde Cabart |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mathilde Cabart |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5085762734 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0982-5960 |
| authorships[3].author.display_name | Ludmilla de Plater |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Ludmilla de Plater |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5035214848 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Fanny Bouquet |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Fanny Bouquet |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5113896530 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Ariel Savina |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ariel Savina |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5089229030 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-2254-0043 |
| authorships[6].author.display_name | Didier Decaudin |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Didier Decaudin |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5030078141 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-5034-1108 |
| authorships[7].author.display_name | Jaafar Bennouna |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Jaafar Bennouna |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5027603422 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-3296-8572 |
| authorships[8].author.display_name | François M. Vallette |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | François M. Vallette |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5054297446 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Lisenn Lalier |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Lisenn Lalier |
| authorships[9].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1535-7163.22507992 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary figures and table from Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10417 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9948999881744385 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Lung Cancer Treatments and Mutations |
| related_works | https://openalex.org/W44670999, https://openalex.org/W2107102981, https://openalex.org/W2365506697, https://openalex.org/W2075312788, https://openalex.org/W4386496024, https://openalex.org/W4385899916, https://openalex.org/W3011987339, https://openalex.org/W2512058705, https://openalex.org/W1969154832, https://openalex.org/W2155615242 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1535-7163.22507992 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1535-7163.22507992 |
| primary_location.id | doi:10.1158/1535-7163.22507992 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1535-7163.22507992 |
| publication_date | 2023-04-03 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.in | 5 |
| abstract_inverted_index.and | 2 |
| abstract_inverted_index.the | 6 |
| abstract_inverted_index.table | 3 |
| abstract_inverted_index.figures | 1 |
| abstract_inverted_index.described | 4 |
| abstract_inverted_index.manuscript</p> | 7 |
| abstract_inverted_index.<p>Supplementary | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 10 |
| citation_normalized_percentile.value | 0.19554923 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |